| |
|
|
|
Soleno Therapeutics Inc  
|
|
2.69 0.06 (0.02%) |
03-05 16:00 |
|
Open: |
2.69 |
Pre close: |
2.63 |
Target:
|
3.92 
|
|
High: |
2.72 |
Low: |
2.57 |
Resistance:
|
3.36
3.92
|
|
Volume: |
534,060 |
Market Cap: |
214M |
Support:
|
2.49
1.95
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.65
|
MACD |
MACD(12,26):
|
0.06  |
|
MA(20): |
2.81 |
Signal(12,26,9): |
0.11 |
|
MA(100): |
2.14 |
Stochastic Oscillator |
%K(14,3):
|
31.87 |
|
MA(250): |
2.27 |
%D(3): |
28.63 |
|
Average Volume(K) |
3-Month: |
33002
|
52-Week |
High:
|
4.39 |
|
10-Days: |
26427 |
Low: |
1.30 |
|
RSI |
RSI(14):
|
53.39 |
Change(%): |
-6.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.687 |
Return on Equity (ttm) |
-115.8 |
Shares Out. (M) |
79.62 |
|
EPS Est. Current Year |
-1.350 |
Return on Assets (ttm) |
-38.6 |
Shares Float (M) |
43.01 |
|
EPS Est. Next Year |
-1.050 |
PEG Ratio |
0.00 |
% Held by Insiders |
16.39 |
|
EPS Est. Next Quarter |
-0.250 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
61.12 |
|
Forward EPS |
-0.640 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
916 |
|
Book Value (p.s.) |
0.600 |
EBITDA (p.s.) |
-0.365 |
P/E |
-3.92 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.48 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-23.43 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-11.76 |
P/CF |
-9.14 |
|
|
|
|
|
|
